A Phase II Study of GT103 in Combination with Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer

Status: Open to Accrual

Learn more: 

• clinicaltrials.gov: #NCT05617313

Study Contact: studies@hoosiercancer.org; (317) 921-2050.